IVERIC bio logo
IVERIC bio ISEE
report update icon

Quarterly report 2023-Q1
added 05-16-2026

IVERIC bio Operating Cycle | ISEE

Annual Operating Cycle IVERIC bio

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
- - - - - 2.41 25.3 31.1 8.49 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
31.1 2.41 16.8

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
PolarityTE PolarityTE
PTE
219 - -0.82 % $ 1.78 M usaUSA
United Therapeutics Corporation United Therapeutics Corporation
UTHR
198 $ 595.86 1.23 % $ 26.4 B usaUSA
Vericel Corporation Vericel Corporation
VCEL
187 $ 59.45 0.7 % $ 2.99 B usaUSA
Veracyte Veracyte
VCYT
57.4 $ 25.08 4.24 % $ 1.97 B usaUSA
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Trevena Trevena
TRVN
99 - -46.58 % $ 31.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
11.5 $ 3.42 -0.15 % $ 577 M singaporeSingapore
Exicure Exicure
XCUR
-4.16 $ 1.05 -2.78 % $ 6.61 M usaUSA
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
558 $ 16.51 4.3 % $ 2.65 B usaUSA
Molecular Templates Molecular Templates
MTEM
4.53 - -23.43 % $ 495 K usaUSA
22nd Century Group 22nd Century Group
XXII
169 $ 1.57 10.56 % $ 289 K usaUSA
Zai Lab Limited Zai Lab Limited
ZLAB
186 $ 26.42 -0.04 % $ 28.9 B chinaChina
Zoetis Zoetis
ZTS
380 $ 82.56 0.12 % $ 36.6 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
1.66 K $ 0.07 9.81 % $ 855 K usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
54.7 K - -2.99 % $ 2.47 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Insmed Incorporated Insmed Incorporated
INSM
400 $ 120.63 0.95 % $ 24 B usaUSA
Novan Novan
NOVN
234 - -24.84 % $ 2.64 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
180 - - $ 546 M usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
257 - - $ 13.6 B usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
59.8 - - $ 29.6 M usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
-65.8 - -1.56 % $ 12.3 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
189 - - $ 35.4 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.4 - - $ 728 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
30.4 - - $ 309 M usaUSA
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
492 $ 4.86 1.04 % $ 787 M usaUSA